학술논문

Hepatic and Intra-abdominal Tuberculosis: 2016 Update
Document Type
Review Paper
Source
Current Infectious Disease Reports. December 2016 18(12):1-8
Subject
Mycobacterium tuberculosis
Tuberculosis
Hepatobiliary tuberculosis
Intra-abdominal tuberculosis
Language
English
ISSN
1523-3847
1534-3146
Abstract
Mycobacterium tuberculosis (TB) infection affects nearly 10 million people a year and causes 1.5 million deaths. TB is common in the immunosuppressed population with 12 % of all new diagnoses occurring in human immune deficiency virus (HIV)-positive patients. Extra-pulmonary TB occurs in 12 % of patients with active TB infection of which 3.5 % is hepatobiliary and 6–38 % is intra-abdominal. Hepatobiliary and intra-abdominal TB can present with a myriad of non-specific symptoms, and therefore, diagnosis requires a high level of suspicion. Accurate and rapid diagnosis requires a multidisciplinary team (MDT) approach using radiology, interventional radiology, surgery and pathology services. Treatment of TB is predominantly medical, yet surgery plays an important role in managing the complications of hepatobiliary and intra-abdominal TB.